NeuroFrontiers
Clinical research and advancements furthering clinicians’ ability to diagnose and treat neurological disorders never stop. And neither does NeuroFrontiers, a series dedicated to covering them all. Here neurology specialists will find essential updates on conditions affecting the nervous system, spinal cord, and overall brain health.
So if you want to stay up to date on the latest clinical research and news on neurological disorders, then look no further. Because NeuroFrontiers is where neurology specialists and great minds explore the mind itself.
- Update frequency
- every 3 days
- Episodes
- 369
- Years Active
- 2008 - 2025
Adverse Childhood and Lifespan Stressors Take a Toll on MS Disease Severity
Guest: Carri Polick, PhD, RN
Two recent studies linked childhood stress and stressors experienced across the lifespan to the severity of multiple scl…
MS in Black and Hispanic Patients: Examining Prevalence and Disease Characteristics
Guest: Mitzi Joi Williams, MD
The CHIMES trial is the first phase IV clinical trial focusing exclusively on Black and Hispanics living with multiple sclerosis …
MS in Black and Hispanic Patients: Examining Prevalence and Disease Characteristics
Guest: Mitzi Joi Williams, MD
The CHIMES trial is the first phase IV clinical trial focusing exclusively on Black and Hispanics living with multiple sclerosis …
Mind Matters: Psychiatric Comorbidity in the Prodromal Phase of MS
Guest: Anibal Chertcoff, MD
According to a recent study, psychiatric conditions like depression, anxiety, bipolar disorder, and schizophrenia ma…
Mind Matters: Psychiatric Comorbidity in the Prodromal Phase of MS
Guest: Anibal Chertcoff, MD
According to a recent study, psychiatric conditions like depression, anxiety, bipolar disorder, and schizophrenia ma…
MS in Children: Exploring Biomarker Research Advancements
The state of research to better detect multiple sclerosis activity is changing rapidly, with emerging assays and other tools seeking to predict the occurrence of M…
MS in Children: Exploring Biomarker Research Advancements
The state of research to better detect multiple sclerosis activity is changing rapidly, with emerging assays and other tools seeking to predict the occurrence of M…
Discussing Disparities in MS Care for Underrepresented Populations
Guest: Tirisham V. Gyang, MD
Guest: Gopika Govindan Kutty, MD
In past studies, it was seen that multiple sclerosis was more prevalent in Whi…
Discussing Disparities in MS Care for Underrepresented Populations
Guest: Tirisham V. Gyang, MD
Guest: Gopika Govindan Kutty, MD
In past studies, it was seen that multiple sclerosis was more prevalent in Whi…
Discussing the Latest in MS Treatment and Disease-Modifying Therapies
Guest: Jay Avasarala, MD, PhD
The three disease-modifying therapies for MS added into the World Health Organization’s (WHO) Essential Medicines …
Discussing the Latest in MS Treatment and Disease-Modifying Therapies
Guest: Jay Avasarala, MD, PhD
The three disease-modifying therapies for MS added into the World Health Organization’s (WHO) Essential Medicines …
Highlights from the 2023 Psych Congress
Guest: Craig Chepke, MD, FAPA
From a women's mental health pre-conference to new mechanisms of action coming into psychiatry for th…
Highlights from the 2023 Psych Congress
Guest: Craig Chepke, MD, FAPA
From a women's mental health pre-conference to new mechanisms of action coming into psychiatry for th…
Diagnosing Suspected MS: A Review of the Updated Guidelines
Guest: Eoin Flanagan, MB, BCh
For the first time since 2008, the International Advisory Committee on Clinical Trials in Multiple Sclerosis have made …
Diagnosing Suspected MS: A Review of the Updated Guidelines
Guest: Eoin Flanagan, MB, BCh
For the first time since 2008, the International Advisory Committee on Clinical Trials in Multiple Sclerosis have made …
Studying the Safety of Discontinuing DMTs in MS Older Adults
Guest: John R. Corboy, MD
Disease-modifying therapies (DMTs) reduce disease activity and slow the progression of disability in multiple sclerosis. Bu…
Studying the Safety of Discontinuing DMTs in MS Older Adults
Guest: John R. Corboy, MD
Disease-modifying therapies (DMTs) reduce disease activity and slow the progression of disability in multiple sclerosis. Bu…
Uncovering Disease Progression in Multiple Sclerosis
A recent study was designed by the International Multiple Sclerosis Genetics Consortium with the goal in mind to find out whether the severity of multiple scler…
Uncovering Disease Progression in Multiple Sclerosis
A recent study was designed by the International Multiple Sclerosis Genetics Consortium with the goal in mind to find out whether the severity of multiple scler…
Examining the Correlation Between HIV & Neurocognitive Disorders
Guest: Santosh Kumar, PhD
In an effort to examine the correlation between HIV-induced aging and Alzheimer’s disease in the United States populatio…